72 related articles for article (PubMed ID: 9888482)
1. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.
Fontanini G; Boldrini L; Chinè S; Pisaturo F; Basolo F; Calcinai A; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Br J Cancer; 1999 Jan; 79(2):363-9. PubMed ID: 9888482
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma.
Rahmani AH; Babiker AY; Alsahli MA; Almatroodi SA; Husain NEOS
Open Access Maced J Med Sci; 2018 Feb; 6(2):263-268. PubMed ID: 29531585
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives.
Zhang S; Cheng Y
Front Oncol; 2023; 13():1142081. PubMed ID: 37188176
[TBL] [Abstract][Full Text] [Related]
4. Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancer.
Abdallah A; Belal M; El Bastawisy A; Gaafar R
Oncol Lett; 2014 Jun; 7(6):2121-2129. PubMed ID: 24932301
[TBL] [Abstract][Full Text] [Related]
5. VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.
Riquelme E; Suraokar M; Behrens C; Lin HY; Girard L; Nilsson MB; Simon G; Wang J; Coombes KR; Lee JJ; Hong WK; Heymach J; Minna JD; Wistuba II
Clin Cancer Res; 2014 Jul; 20(14):3849-61. PubMed ID: 24850841
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.
Langsenlehner T; Thurner EM; Renner W; Gerger A; Kapp KS; Langsenlehner U
Strahlenther Onkol; 2014 Apr; 190(4):364-9. PubMed ID: 24435801
[TBL] [Abstract][Full Text] [Related]
7. Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC).
Schmid-Bindert G
Target Oncol; 2013 Mar; 8(1):15-26. PubMed ID: 23371029
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.
Cao B; Jia J; Ma L; Di L; Song G; Yuan Y; Ma B; Zhu Y; Yu J; Wang X; Zhou X; Lyerly HK; Ren J
Clin Transl Oncol; 2012 Aug; 14(8):575-85. PubMed ID: 22855139
[TBL] [Abstract][Full Text] [Related]
9. Protein signature of lung cancer tissues.
Mehan MR; Ayers D; Thirstrup D; Xiong W; Ostroff RM; Brody EN; Walker JJ; Gold L; Jarvis TC; Janjic N; Baird GS; Wilcox SK
PLoS One; 2012; 7(4):e35157. PubMed ID: 22509397
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India).
Naik NA; Bhat IA; Afroze D; Rasool R; Mir H; Andrabi SI; Shah S; Siddiqi MA; Shah ZA
Tumour Biol; 2012 Jun; 33(3):833-9. PubMed ID: 22231433
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.
Kelly RJ; Rajan A; Force J; Lopez-Chavez A; Keen C; Cao L; Yu Y; Choyke P; Turkbey B; Raffeld M; Xi L; Steinberg SM; Wright JJ; Kummar S; Gutierrez M; Giaccone G
Clin Cancer Res; 2011 Mar; 17(5):1190-9. PubMed ID: 21224376
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast.
Shivakumar S; Prabhakar BT; Jayashree K; Rajan MG; Salimath BP
J Cancer Res Clin Oncol; 2009 Apr; 135(4):627-36. PubMed ID: 18936974
[TBL] [Abstract][Full Text] [Related]
13. UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.
Nagai N; Mukai K; Hirata E; Jin HH; Komatsu M; Yunokawa M
Med Oncol; 2008; 25(2):214-21. PubMed ID: 17968681
[TBL] [Abstract][Full Text] [Related]
14. New molecularly targeted therapies for lung cancer.
Sun S; Schiller JH; Spinola M; Minna JD
J Clin Invest; 2007 Oct; 117(10):2740-50. PubMed ID: 17909619
[TBL] [Abstract][Full Text] [Related]
15. Expression of endothelin 1 and its angiogenic role in meningiomas.
Boldrini L; Pistolesi S; Gisfredi S; Ursino S; Alì G; Pieracci N; Basolo F; Parenti G; Fontanini G
Virchows Arch; 2006 Nov; 449(5):546-53. PubMed ID: 17013629
[TBL] [Abstract][Full Text] [Related]
16. The induction of vascular endothelial growth factor by ultrafine carbon black contributes to the increase of alveolar-capillary permeability.
Chang CC; Chiu HF; Wu YS; Li YC; Tsai ML; Shen CK; Yang CY
Environ Health Perspect; 2005 Apr; 113(4):454-60. PubMed ID: 15811836
[TBL] [Abstract][Full Text] [Related]
17. Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer.
Demirkazik A; Akbulut H; Ulger AF; Arican A; Ozer I; Acikgoz N; Icli F
Ann Saudi Med; 2004; 24(6):473-5. PubMed ID: 15646168
[No Abstract] [Full Text] [Related]
18. Expression of P53, P21 in human lung adenocarcinoma A549 cell strains under hypoxia conditions and the effect of TSA on their expression.
Huang H; Zhang Z; Xu Y; Shao J
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):359-61. PubMed ID: 15015635
[TBL] [Abstract][Full Text] [Related]
19. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma.
Fontanini G; Faviana P; Lucchi M; Boldrini L; Mussi A; Camacci T; Mariani MA; Angeletti CA; Basolo F; Pingitore R
Br J Cancer; 2002 Feb; 86(4):558-63. PubMed ID: 11870537
[TBL] [Abstract][Full Text] [Related]
20. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
